2016
DOI: 10.1016/bs.acc.2015.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Inborn Errors of Metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0
8

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(41 citation statements)
references
References 123 publications
0
33
0
8
Order By: Relevance
“…Generation of a comprehensive understanding of metabolic reactions in humans is important for several reasons: first, altered metabolite levels can cause clinical symptoms and diseases, as exemplified by elevated serum urate levels and gout and by many inborn errors of metabolism (IEMs) 5,6 . Such metabolites represent attractive therapeutic targets to prevent and treat these diseases.…”
mentioning
confidence: 99%
“…Generation of a comprehensive understanding of metabolic reactions in humans is important for several reasons: first, altered metabolite levels can cause clinical symptoms and diseases, as exemplified by elevated serum urate levels and gout and by many inborn errors of metabolism (IEMs) 5,6 . Such metabolites represent attractive therapeutic targets to prevent and treat these diseases.…”
mentioning
confidence: 99%
“…A minority of IEMs are inherited in an autosomal dominant (AD) pattern. Another rare mode of inheritance is IEMs linked to mitochondrial DNA only of maternal origin, as in subsets of respiratory chain disorders [50,51]. The pathophysiology behind most IEM disorders is a specific enzyme defect that results in an inadequate conversion of substrates into their direct products.…”
Section: Inheritance and Causesmentioning
confidence: 99%
“…The treatment and management of IEMs are always individualized, based on each patient’s diagnosis and phenotype, and there is broad heterogeneity even within each category ( Argmann et al , 2016 ). Despite this heterogeneity in management approaches, the specific treatment usually falls into one of three classes: (I) enzyme replacement therapy, to replenish the deficient enzyme; (II) substrate reduction therapy; or (III) dietary treatment, although organ transplantation is also used in some cases ( Ezgu, 2016 ). Additional non-specific treatment may be necessary, depending on the presence of comorbidities, such as neuropsychiatric disorders in PKU patients ( Bilder et al , 2017 ), or renal and neurologic impairment in patients with tyrosinemia type I ( Santra et al , 2008 ; Chinsky et al , 2017 ).…”
Section: Inborn Errors Of Metabolism (Iem)mentioning
confidence: 99%